The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC Rotterdam

BACKGROUND: The ERSPC study has demonstrated that prostate-specific antigen (PSA)-based screening results in a relative increase in diagnosis of (low-risk) prostate cancer (PCa) and a reduction in metastatic disease and PCa mortality. OBJECTIVE: To evaluate the burden of PCa among men randomized to...

Descripción completa

Detalles Bibliográficos
Autores principales: Remmers, Sebastiaan, Nieboer, Daan, Roobol, Monique J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Prostate Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175721/
https://www.ncbi.nlm.nih.gov/pubmed/37187725
http://dx.doi.org/10.1016/j.euros.2023.02.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175721/
https://www.ncbi.nlm.nih.gov/pubmed/37187725
http://dx.doi.org/10.1016/j.euros.2023.02.013

Ejemplares similares